Brid Gene Biosciences
Biotechnology, 75 Nicholson Ln, San Jose, California, 95134, United States, 11-50 Employees
Phone Number: 14*********
Who is BRIDGENE BIOSCIENCES
BridGene Biosciences is a biotechnology company focused on discovering and developing innovative small molecules that drug high value yet previously undruggable targets, providing new pat...
Read More
-
Headquarters: 75 Nicholson Ln, San Jose, California, 95134, United States
-
Date Founded: 2018
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
Does something look wrong? Fix it. | View contact records from BRIDGENE BIOSCIENCES
BridGene Biosciences Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding BridGene Biosciences
Answer: BridGene Biosciences's headquarters are located at 75 Nicholson Ln, San Jose, California, 95134, United States
Answer: BridGene Biosciences's phone number is 14*********
Answer: BridGene Biosciences's official website is https://bridgenebiosciences.com
Answer: BridGene Biosciences's revenue is $1 Million to $5 Million
Answer: BridGene Biosciences's SIC: 2834
Answer: BridGene Biosciences has 11-50 employees
Answer: BridGene Biosciences is in Biotechnology
Answer: BridGene Biosciences contact info: Phone number: 14********* Website: https://bridgenebiosciences.com
Answer: BridGene Biosciences is a biotechnology company focused on discovering and developing innovative small molecules that drug high value yet previously undruggable targets, providing new paths to treat diseases. Currently, about 90% of disease-causing proteins cannot be targeted by traditional therapies due to the lack of a known addressable binding site. BridGene intends to change this by using its proprietary Chemoproteomics platform, IMTACTM (Isobaric Mass Tagged Affinity Characterization). IMTACTM enables the screening of small molecules against all the proteins in live cells to discover drug candidates for high value and hard-to-drug targets that cause disease. Bringing new drugs to previously undruggable targets means new therapies with new mechanisms for unmet medical needs. The ultimate goal is to expand the available approaches to treat disease at unprecedented speed and success rate.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Powered by
Sign in to CIENCE GO Data to uncover contact details
Free credits every month